Form 8-K - Current report:
SEC Accession No. 0000950170-25-066420
Filing Date
2025-05-08
Accepted
2025-05-08 08:05:45
Documents
15
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20250508.htm   iXBRL 8-K 58232
2 EX-99.1 rkda-ex99_1.htm EX-99.1 63423
3 EX-99.2 rkda-ex99_2.htm EX-99.2 355228
4 GRAPHIC img192114479_0.jpg GRAPHIC 9353
5 GRAPHIC img193038000_0.jpg GRAPHIC 9353
  Complete submission text file 0000950170-25-066420.txt   640821

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20250508.xsd EX-101.SCH 24852
17 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20250508_htm.xml XML 4670
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 25923985
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)